Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Respiration ; 101(8): 709-716, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35717945

RESUMO

Advanced chronic obstructive pulmonary disease (COPD) might result in chronic hypercapnic ventilatory failure. Similar to neuromuscular and restrictive chest wall diseases, long-term non-invasive positive pressure ventilation (NPPV) is increasingly used in chronic hypercapnic COPD. This review describes the methods, patient selection, ventilatory strategies, and therapeutic effects of long-term Home-NPPV based on randomized controlled clinical trials published since 1985 in English language retrieved from the databases PubMed and Scopus. Long-term NPPV is feasible and effective in stable, non-exacerbated COPD patients with daytime hypercapnia with arterial pressure of carbon dioxide (PaCO2) levels ≥50 mm Hg (6.6 kPa), if the applied ventilatory pressures and application times improve baseline hypercapnia by at least 20%. Patients who survived an acute hypercapnic exacerbation might benefit from long-term NPPV if hypercapnia persists 2-4 weeks after resolution of the exacerbation. Pressure-controlled ventilation or pressure-support ventilation with adequate minimum backup breathing frequencies, in combination with nasal masks or oronasal masks have been successfully used in all larger clinical trials. Ventilatory strategies with mean inspiratory pressures of up to 28 cm H2O are well-tolerated by patients, but limitations exist in patients with impaired cardiac performance. Home-NPPV with a PaCO2-reductive approach might be considered as an additional treatment option in patients with stable chronic hypercapnic COPD.


Assuntos
Ventilação não Invasiva , Doença Pulmonar Obstrutiva Crônica , Insuficiência Respiratória , Humanos , Hipercapnia/etiologia , Hipercapnia/terapia , Ventilação não Invasiva/métodos , Respiração com Pressão Positiva/métodos , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/terapia , Insuficiência Respiratória/terapia
2.
Pneumologie ; 75(12): 971-980, 2021 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-34233361

RESUMO

Multidrug-resistant tuberculosis (MDR-TB) is of low proportion in comparison to the total number of TB patients, however, due to the necessity of a complex medication with potentially severe and life threatening adverse reactions, long term sequelae, and unfavorable outcome special attention is essential. We report the case of a 30-year-old geriatric nurse with a history of chronic cough and hereditary alpha-1-anti-trypsin deficiency (AATD), who suffered from MDR-TB and experienced a number of severe adverse reactions.


Assuntos
Tosse , Tuberculose Resistente a Múltiplos Medicamentos , Adulto , Idoso , Antituberculosos/uso terapêutico , Humanos , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico
3.
Infect Control Hosp Epidemiol ; 41(10): 1209-1211, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32489162

RESUMO

We investigated potential transmissions of a symptomatic SARS-CoV-2-positive physician in a tertiary-care hospital who worked for 15 cumulative hours without wearing a face mask. No in-hospital transmissions occurred, despite 254 contacts among patients and healthcare workers. In conclusion, exposed hospital staff continued work, accompanied by close clinical and virologic monitoring.


Assuntos
Infecções por Coronavirus/diagnóstico , Transmissão de Doença Infecciosa do Profissional para o Paciente , Médicos , Pneumonia Viral/diagnóstico , Betacoronavirus/isolamento & purificação , COVID-19 , Busca de Comunicante , Infecções por Coronavirus/transmissão , Infecção Hospitalar/transmissão , Infecção Hospitalar/virologia , Feminino , Alemanha , Hospitais , Humanos , Máscaras , Pandemias , Pneumonia Viral/transmissão , SARS-CoV-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA